Trial Profile
A Phase II Trial of Pre-Operative Taxol and Carboplatin in Women With Newly Diagnosed Locally Advanced Operable Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2018
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer; Ductal carcinoma; Inflammatory breast cancer
- Focus Therapeutic Use
- 21 Nov 2007 Updated start date from NCT (last updated 16/11/07)
- 01 Mar 2007 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Sep 2005 New trial record.